128 related articles for article (PubMed ID: 11123709)
1. Pharmacological and molecular characterization of muscular cholecystokinin receptors in the human lower oesophageal sphincter.
González AA; Farré R; Monés J; Capellà G; Clavé P
Neurogastroenterol Motil; 2000 Dec; 12(6):539-46. PubMed ID: 11123709
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.
Clavé P; González A; Moreno A; López R; Farré A; Cussó X; D'Amato M; Azpiroz F; Lluís F
Gastroenterology; 1998 Sep; 115(3):597-604. PubMed ID: 9721157
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):406-13. PubMed ID: 12690433
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter.
Rattan S; Goyal RK
Gastroenterology; 1986 Jan; 90(1):94-102. PubMed ID: 2998919
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin and gastrin induce cell contraction in pig ileum by interacting with different receptor subtypes.
Botella A; Delvaux M; Berry P; Frexinos J; Bueno L
Gastroenterology; 1992 Mar; 102(3):779-86. PubMed ID: 1537515
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.
Boulant J; Mathieu S; D'Amato M; Abergel A; Dapoigny M; Bommelaer G
Gut; 1997 May; 40(5):575-81. PubMed ID: 9203932
[TBL] [Abstract][Full Text] [Related]
7. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by estradiol in ovariectomized rats.
Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
Scand J Gastroenterol; 2002 Oct; 37(10):1133-9. PubMed ID: 12408516
[TBL] [Abstract][Full Text] [Related]
8. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
Motomura Y; Chijiiwa Y; Iwakiri Y; Nawata H
Life Sci; 1997; 60(7):499-504. PubMed ID: 9042379
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
Wang SX
Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
[TBL] [Abstract][Full Text] [Related]
11. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves.
Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG
Regul Pept; 1999 Jun; 82(1-3):19-33. PubMed ID: 10458643
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin contracts isolated human and monkey iris sphincters; a study with CCK receptor antagonists.
Almegård B; Stjernschantz J; Bill A
Eur J Pharmacol; 1992 Feb; 211(2):183-7. PubMed ID: 1612109
[TBL] [Abstract][Full Text] [Related]
14. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
Staley J; Jensen RT; Moody TW
Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
[TBL] [Abstract][Full Text] [Related]
15. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
16. Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin--responsive human gastric adenocarcinoma cells in vitro.
Piontek MK; Hengels KJ
Anticancer Res; 1993; 13(3):715-20. PubMed ID: 8317902
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans.
Zerbib F; Bruley Des Varannes S; Scarpignato C; Leray V; D'Amato M; Rozé C; Galmiche JP
Am J Physiol; 1998 Dec; 275(6):G1266-73. PubMed ID: 9843762
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
Wu CL; Doong ML; Wang PS
Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
[TBL] [Abstract][Full Text] [Related]
19. Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects.
Hirsch DP; Mathus-Vliegen EM; Holloway RH; Fakhry N; D'Amato M; Boeckxstaens GE
Dig Dis Sci; 2002 Nov; 47(11):2531-7. PubMed ID: 12452391
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
